분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2011-08-16 13:33:42 , Hit : 2612
 New Treatment Option for Advanced Prostate Cancer

ScienceDaily (Aug. 14, 2011) — Prostate cancer that has become resistant to hormone treatment and that does not respond to radiation or chemotherapy requires new methods of treatment. By attacking stem cell-like cells in prostate cancer, researchers at Lund University are working on a project to develop a new treatment option.

An interdisciplinary project is underway between two research groups, in which senior researcher Rebecka Hellsten and Professor Anders Bjartell at the Faculty of Medicine's division for Urological Cancer Research, Skåne University Hospital in Malmö, and Professor Olov Sterner and Assistant Professor Martin Johansson at the Lund University division of Organic Chemistry recently published their latest research findings in the scientific online journal PLoS ONE.

"Prostatic tumours are thought to consist only of about 0.1 per cent cancer stem cells, but if you are not successful in eradicating that tumour cell population, there is a risk of subsequent uncontrolled growth of the tumour. The cancer stem cells are often unresponsive to both hormonal treatment and to chemotherapy, so it is essential to develop a direct treatment towards all types of cancer cells," says Anders Bjartell.

Exploring the tumour biology of prostate cancer, the research group have now observed that the protein STAT3 is active in the stem cell-like cells. In their previous studies, they have proven that the natural compound galiellalactone affects STAT3 and has inhibitory effects on the growth of prostate cancer.

Through the development of new specific STAT3-inhibitors with galiellalactone as a model, the researchers hope to develop targeted therapies that attack the stem cell-like cancer cells in prostate cancer and prevent the tumour from growing and spreading.

Story Source:

The above story is reprinted (with editorial adaptations by ScienceDaily staff) from materials provided by Lund University, via AlphaGalileo.

--------------------------------------------------------------------------------

Journal Reference:

Rebecka Hellsten, Martin Johansson, Anna Dahlman, Olov Sterner, Anders Bjartell. Galiellalactone Inhibits Stem Cell-Like ALDH-Positive Prostate Cancer Cells. PLoS ONE, 2011; 6 (7): e22118 DOI: 10.1371/journal.pone.0022118







867   Turning T-cells into Cancer Killers  이성욱 2011/08/12 2557
866   Next Generation: Hundreds of Cell-Analyses at Once  이성욱 2011/08/12 2151
  New Treatment Option for Advanced Prostate Cancer  이성욱 2011/08/16 2612
864   Cancer’s Secrets Come Into Sharper Focus  이성욱 2011/08/17 2190
863   How Caffeine Fights Cancer  이성욱 2011/08/17 2165
862   Bacteria Kamikazes  이성욱 2011/08/17 2702
861   Murdoch researchers attempt to thwart hep C virus  이성욱 2011/08/19 3802
860   Toxic antibodies blitz tumours  이성욱 2011/08/25 2231
859   Gene Therapy for Immune Disorder Lasts Nine Years, Two New Studies Show  이성욱 2011/08/25 2505
858   An RNA Switch for Stem Cells  이성욱 2011/08/31 2463
857   Engineered Viruses Selectively Kill Cancer Cells  이성욱 2011/09/02 2471
856   Genetic circuit kills cancer cells using unique microRNAs  이성욱 2011/09/08 4970
855   Researchers Successfully Perform First Injection of Cultured Red Blood Cells in Human Donor  이성욱 2011/09/08 2378
854   Breast-cancer gene keeps DNA under wraps  이성욱 2011/09/10 2298
853   Haploid Stem Cells  이성욱 2011/09/10 2623
852   Obscure Organelle in Stem Cells and Cancer  이성욱 2011/09/13 2397
851   UK Duo Generates Haploid Mouse Stem Cells  이성욱 2011/09/14 2438
850   Can a Form of HIV Actually Cure Cancer?  이성욱 2011/09/17 2388
849   Mammoth blood proteins could be used in major surgery  이성욱 2011/09/20 3175
848   Ribosomes in Control  이성욱 2011/09/20 2650

[이전 10개] [1].. 21 [22][23][24][25][26][27][28][29][30]..[64] [다음 10개]
 

Copyright 1999-2023 Zeroboard / skin by ROBIN